Savant Capital, LLC Dexcom Inc Put Options Transaction History

Savant Capital, LLC

3 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2022 Oct 28, 2022	BUY	$76.35 - $94.18 $2.3 Million - $2.83 Million	30,100 Added 2508.33%	31,300 $2.52 Million
Q2 2022 Jul 22, 2022	BUY	$67.99 - $132.89 $61,190 - $119,600	900 Added 300.0%	1,200 $89,000
Q4 2020 Feb 03, 2021	BUY	$78.0 - $104.5 $23,400 - $31,350	300 New	300 $111,000

1,013

351M

5.51M

5.6M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $29.5B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Savant Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Savant Capital, LLC with notifications on news.